Alkermes Honors Women's Equality DayNORTHAMPTON, MA / ACCESSWIRE / August 28, 2023 / Alkermes
Sarissa Issues Presentation Highlighting Sarissa Nominees Are Qualified to Create Value for Alkermes Shareholders
Sarissa Capital Management LP (“Sarissa”) today issued a presentation detailing the need for shareholder representation on the board of Alkermes plc (
NASDAQALKS) accessible at the link below:
Independent Proxy Advisory Firm ISS Agrees With Sarissa Capital That Shareholders’ Interests Would Be Best Served With Direct Shareholder Representation on the Alkermes Board
Sarissa Capital Management LP (“Sarissa”) today made the following additional statement regarding the recent report on Alkermes plc (
NASDAQALKS) issued by independent proxy advisory firm Institutional Shareholder Services Inc. (“ISS”):
Independent Proxy Advisory Firm ISS Concludes That Sarissa Capital Has Made a Compelling Case for Change to the Alkermes Board
Sarissa Capital Management LP (“Sarissa”) today made the following announcement regarding the conclusion reached by independent proxy advisory firm ISS that Sarissa has made a compelling case for change to the board of directors of Alkermes plc (
NASDAQALKS):
Sarissa Issues Presentation Highlighting the Need for Shareholder Representation on the Alkermes Board
Sarissa Capital Management LP (“Sarissa”) today issued a presentation detailing the need for shareholder representation on the board of Alkermes plc (
NASDAQALKS) accessible at the link below:
Sarissa Capital Highlights Misleading Claims Made by Alkermes in Its Attempt to Thwart Shareholder Representation on the Board
Sarissa Capital Management LP (“Sarissa”) today issued a presentation detailing the need for shareholder representation on the board of Alkermes (
NASDAQALKS) accessible at the link below:
Sarissa Capital Comments on Alkermes Annual Meeting
Sarissa Capital Management LP (“Sarissa”) today made the following statement on Alkermes PLC (
NASDAQALKS) regarding how it intends to vote at the upcoming Alkermes annual meeting and the reasons therefor:
Small-Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment (AXSM, AWKNF, BICX, OPNT, ALKS, PFE, AMPH, OMER)The addiction treatment space has been pummeled along with everything else in the growth side of the stock market so far in 2022. For long-term investors, this could represent a huge gift, especially as some of the stocks in this space are also working in new domains and technologies, including psychedelic treatment strategies that may offer enormous long-term potential (1).
Sarissa Condemns Poor Corporate Governance at Alkermes
Sarissa Capital Management LP (“Sarissa”) today made the following statement regarding Alkermes plc (
NASDAQALKS):
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028Palm Beach, FL – May 26, 2022 – FinancialNewsMedia.com News Commentary – Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis, Alzheimer’s, Parkinson’s, among others. According to Public Health England, the number of individuals with multiple sclerosis has increased over the last few years. This increase […]
Rising Number of Mental Health Disorders Fuel Advancing Initiatives to Reduce Psychiatric and Neurological ConditionsPalm Beach, FL –– March 8, 2022 – FinancialNewsMedia.com News Commentary – According to a report from Grand View Research “High unmet medical needs and government initiatives to reduce the psychiatric and neurological disorders are driving the market for central nervous system (CNS) therapeutic. According to WHO, the global economy loses due to depression and […]
